2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Myeloma: KRd vs. VRd for Initial Therapy of Newly Diagnosed Disease, Weekly Selinexor Combo vs. Vd After Prior Therapy, Safety and Tolerability of Belantamab Mafodotin + Bortezomib/Dexamethasone in R/R Disease
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
344 views
July 22, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology